Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
3.780
+0.130 (3.56%)
At close: Jun 26, 2026, 4:00 PM EDT
3.850
+0.070 (1.85%)
After-hours: Jun 26, 2026, 7:34 PM EDT
Eledon Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Eledon Pharmaceuticals stock have an average target of 8.67, with a low estimate of 8.00 and a high estimate of 10. The average target predicts an increase of 129.37% from the current stock price of 3.78.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Eledon Pharmaceuticals stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Feb '26 | Mar '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 7 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Noble Financial | Noble Financial | Buy Reiterates $10 | Buy | Reiterates | $10 | +164.55% | Jun 23, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Buy Reiterates $8 | Buy | Reiterates | $8 | +111.64% | Jun 23, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Reiterates $6 → $8 | Buy | Reiterates | $6 → $8 | +111.64% | Jun 22, 2026 |
| Craig-Hallum | Craig-Hallum | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jan 23, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.87
from -0.52
EPS Next Year
-0.72
from -0.87
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.77 | -0.68 | |
| Avg | -0.87 | -0.72 | |
| Low | -0.92 | -0.80 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.